SMS Pharmaceuticals vs Eli Lilly and: Fair Value & Quality
Both stocks run through our valuation models. Here is how SMS Pharmaceuticals (SMSPHARMA) and Eli Lilly and (LLY) compare, as of Aug 18, 2026.
As of Aug 18, 2026, Fair Value Calculator sees SMS Pharmaceuticals as the less overvalued of the two: SMS Pharmaceuticals trades at ₹358 versus a fair value of ₹189 (-47%), while Eli Lilly and trades at $1,183 versus $389 (-67%).
SMS Pharmaceuticals
SMSPHARMA.NSE · INR · Health Care
-47%
upside to fair value
overvalued
Price₹358
Fair Value₹189
Quality36/100
Eli Lilly and
LLY · USD · Health Care
-67%
upside to fair value
overvalued
Price$1,183
Fair Value$389
Quality69/100
Get comparisons like this free by email every month: the most undervalued quality stocks.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
SMS PharmaceuticalsEli Lilly and
Valuation
32.1×P/E (TTM)42.2×
4.41×P/S (TTM)14.67×
4.98×P/B39.94×
23.6×EV/EBITDA30.2×
0.94×PEG1.54×
0.1%Dividend yield0.5%
₹0.40Dividend per share$6.23
Profitability
12%Net margin35%
13%Operating margin49%
14%Return on equity107%
7%Return on assets21%
Growth
-4%Revenue growth (YoY)56%
19.3%Avg. growth/yr (3Y)31.7%
9.6%Avg. growth/yr (5Y)21.6%
Balance & size
0.22×Debt / equity1.54×
$411MMarket cap$1.1T
expensiveGrowth qualitymixed
Eli Lilly and leads: 6 to 8 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
SMS Pharmaceuticalsof which business quality 37 · market factors 65Eli Lilly andof which business quality 65 · market factors 81
ProfitabilityMargins and returns on capital today
45
85
Quality GrowthAre margins and returns improving?
56
86
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
18
15
Low VolatilityCalm price path (market factor)
64
77
MomentumPrice trend over the last 3–12 months (market factor)
59
76
52W MomentumDistance to the 52-week high (market factor)
77
95
Net IssuanceBuybacks instead of dilution
29
93
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
SMS Pharmaceuticals
DCF Models₹11.58
Earnings-Based₹106
Dividend Discount₹6.67
Multiples₹205
Asset-Based₹56.22
Economic Profit₹114
Growth Earnings₹189
17 of 17 models see the stock below the current price.
Eli Lilly and
DCF Models$334
Earnings-Based$239
Dividend Discount$115
Multiples$358
Asset-Based$19.94
Growth DCF$187
Economic Profit$347
Growth Earnings$375
26 of 26 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
SMS Pharmaceuticals
Bear ₹132Fair Value ₹189Bull ₹245
₹358 = current price (white tick)
Eli Lilly and
Bear $216Fair Value $389Bull $582
$1,183 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
SMS Pharmaceuticals · Health Care
Quality score36 · bottom 25%
Fair value upside-47% · below median
Eli Lilly and · Health Care
Quality score69 · Top 25%
Fair value upside-67% · bottom 25%
Bottom line
As of Aug 18, 2026, Fair Value Calculator sees SMS Pharmaceuticals as the less overvalued of the two: SMS Pharmaceuticals trades at ₹358 versus a fair value of ₹189 (-47%), while Eli Lilly and trades at $1,183 versus $389 (-67%).
Eli Lilly and has the higher quality score (69/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
